Jiangsu Pharmaceutical Research Institute Co., Ltd

Using Twynsta® certified by Boehringer Ingelheim as the reference preparation and Telmisartan Amlodipine Tablets produced by our company as the test preparation, a single-center, randomized, open, single-dose, two-preparation, three-period, three-sequence, partially repeated crossover design clinical study was conducted to evaluate the bioequivalence of the two preparations under fasting and postprandial conditions.